These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8872829)

  • 1. Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment.
    Richards RJ; Thakur V; Reisin E
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S59-64. PubMed ID: 8872829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-associated hypertension: hypothesized link between etiology and selection of therapy.
    Reisin E; Tuck ML
    Blood Press Monit; 1999; 4 Suppl 1():S23-6. PubMed ID: 10822414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
    Doggrell SA
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):119-25. PubMed ID: 15834464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic considerations in hypertension.
    Tuck ML
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):355S-365S. PubMed ID: 2078323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension.
    Zhang R; Thakur V; Morse S; Reisin E
    J Hum Hypertens; 2002 Dec; 16(12):819-27. PubMed ID: 12522462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity in hypertension: effects on prognosis and treatment.
    Kaplan NM
    J Hypertens Suppl; 1998 Jan; 16(1):S35-7. PubMed ID: 9534095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable].
    Pischon T; Sharma AM
    MMW Fortschr Med; 2001 Nov; 143(48):34-8. PubMed ID: 11770373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of hypertension in obesity.
    Narkiewicz K
    Obes Rev; 2006 May; 7(2):155-62. PubMed ID: 16629872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of arterial hypertension in obese patients.
    Wenzel UO; Benndorf R; Lange S
    Semin Nephrol; 2013 Jan; 33(1):66-74. PubMed ID: 23374895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and obesity.
    Dustan HP
    Prim Care; 1991 Sep; 18(3):495-507. PubMed ID: 1946785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy in the obese hypertensive patient.
    Chrostowska M; Szczech R; Narkiewicz K
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):487-92. PubMed ID: 16914960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.